Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma

Fig. 2

H3K27M is a negative prognostic marker in paediatric thalamic glioma. SickKids cohort (a) and )(b) Canadian cohort were tested for association between H3K27M-status and survival. Sample stratification based on histological grade showed H3K27M a significant prognostic marker in high grade (c) and low grade (d). Histology and H3K27M status combined (e) revealed clinical disease stratification

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us